Urgent.News

600+ sources. One page. See who else covered it.

Editions

Culture

North Korea warns of new ‘deterrent’ ahead of U.S.-South drills

Pyongyang describes the 11-day annual exercises due to begin on Monday as rehearsals for an invasion.

North Korea warns of new ‘deterrent’ ahead of U.S.-South drills

Seoul, South Korea - North Korea has expressed strong opposition to upcoming joint military drills by the United States and South Korea, warning that it could respond with more aggressive measures to ensure its security. The 11-day exercises, scheduled to begin on Monday, are an annual affair designed to prepare the U.S. and South Korea to defend against North Korea, which is viewed as a nuclear threat by its southern neighbors.

Pyongyang has dismissed the drills as rehearsals for an invasion and recently fired a ballistic missile over the Sea of Japan, further escalating tensions. A spokesperson for North Korea's Foreign Ministry stated that the country will respond to any new level of threat with a corresponding increase in its own deterrent capabilities.

The statement emphasized that North Korea will not tolerate the confrontational situation being created by the enemy states and will express its stance more clearly through the responsible and decisive exercise of the right to legitimate self-defense. The drills, known as "Ulchi Freedom Shield," will involve 18,000 South Korean troops and 28,500 U.S. personnel, with North Korea accusing the exercises of preparing soldiers for a potential fight against North Korean troops who have gained experience deploying alongside Russian forces in Ukraine.

Written by urgent.news from Japan Times's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

Read the original at japantimes.co.jp →

More in Culture

AbTis Defeats Ajinomoto in U.S. Patent Trial

Domestic biotech company AbTis has won a U.S. patent dispute with a Japanese company.AbTis announced on August 14 that it won the Inter Partes Review (IPR) filed by Japan’s Ajinomoto at the U.S.

  • U.S. biotech firm AbTis wins patent dispute against Ajinomoto on August 14.
  • PTAB maintains AbTis' core ADC platform technology patent, AbClick.
  • Ajinomoto's invalidation claims dismissed due to patent law violations.